Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression

BACKGROUND: Patients with anxious major depressive disorder (MDD) are more likely to have poorer outcomes than those with non-anxious MDD. However, the effect of esketamine on adolescents with anxious versus non-anxious MDD has remained unknown. AIMS: We compared the efficacy of esketamine in adoles...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Xiaofeng, Wang, Chengyu, Zhang, Fan, Liu, Haiyan, Fu, Ling, Li, Weicheng, Ye, Yanxiang, Hu, Zhibo, Mai, Siming, Ning, Yuping, Zhou, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314616/
https://www.ncbi.nlm.nih.gov/pubmed/37396782
http://dx.doi.org/10.1136/gpsych-2023-101007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314616/
https://www.ncbi.nlm.nih.gov/pubmed/37396782
http://dx.doi.org/10.1136/gpsych-2023-101007

Ejemplares similares